Ebola Is Coming and the U.S. Gov't Screwed Up Treatment

ZMapp is a treatment for Ebola that uses human antibodies to create an immunity to the virus. The treatment has been given to some Ebola victims and is credited with saving lives. But there have been no large clinical trials of ZMapp yet. Bloomberg Businessweek's Brendan Greeley explains how government bureaucracy stymied efforts to develop and test ZMapp

Related Videos